SSB
ALDX icon

Sandy Spring Bank’s Aldeyra Therapeutics ALDX Stock Holding History

Sandy Spring Bank’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-250
Closed -$2K – 990
2020
Q4 		$2K Buy
+250
New +$1.75K ﹤0.01% 872
2020
Q3 		– Sell
-300
Closed -$1K – 925
2020
Q2 		$1K Buy
+300
New +$1.1K ﹤0.01% 851

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sandy Spring Bank's ALDX Position: Q1 2021 in Review

Sandy Spring Bank sold out of Aldeyra Therapeutics (ALDX) in Q1 2021, closing a stake of 250 shares — an estimated $2K sold.

Sandy Spring Bank first reported a position in ALDX in Q2 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2020. 108 funds tracked by Wall St. Rank hold ALDX as of Q1 2021.

  • Sandy Spring Bank reported no remaining Aldeyra Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Sandy Spring Bank sold 250 Aldeyra Therapeutics shares in Q1 2021, an estimated $2K.
  • Sandy Spring Bank first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 2 quarters.
  • Sandy Spring Bank's Aldeyra Therapeutics position peaked at $2K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2021.

Based on Sandy Spring Bank's 13F filing for Q1 2021, filed 3 May 2021.